Table 2.
Phenotypic characterization of the strains derived from this study.
Strain | Minimal inhibitory concentration (μg/ml) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
GEN | AMP | CHL | COL | CIP | FOS | TET | RIF | TRM | EtB | |
MG1655 | 0.25 | 16 | 4 | 1 | 0.008 | 0.25 | 0.25 | 4 | 0.5 | 64 |
ΔdnaQ | 0.25 | 32 | 4 | 1 | 0.016 | 1 | 2 | 4 | 0.5 | 32 |
CIM5H | 512 | 16 | 0.25 | 2 | 0.008 | 16 | 0.5 | ≥16 | 0.25 | ≤8 |
CIM5N | 512 | 32 | 1 | 2 | 0.008 | 32 | 1 | ≥16 | 2 | 128 |
CIM8C | 512 | 16 | 1 | 2 | 0.008 | 32 | 0.5 | ≥16 | 0.5 | 32 |
CIM8M | 512 | 8 | ≤0.125 | 0.5 | 0.008 | 32 | 0.5 | ≥16 | 0.125 | 64 |
CIQ1E | 1024 | 64 | 0.25 | 2 | 0.008 | 256 | 0.125 | 4 | 0.25 | 32 |
CIQ1G | 1024 | 16 | 0.25 | 2 | 0.008 | 16 | 0.5 | ≤1 | 0.063 | 512 |
CIQ2J | 512 | 128 | 1 | 1 | 0.008 | 64 | 0.5 | 2 | 0.5 | 64 |
CIQ4J | 512 | 64 | 2 | 2 | 0.008 | 64 | 1 | ≥16 | 1 | 64 |